Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic

Aliment Pharmacol Ther. 2020 Jun;51(12):1441-1442. doi: 10.1111/apt.15759. Epub 2020 May 14.

Authors

Samantha Jane Benson-Pope¹, Richard B Gearry^{1

2}

Affiliations

¹ Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand.
² Department of Medicine, University of Otago, Christchurch, New Zealand.

Abstract

LINKED CONTENT

This article is linked to King et al papers. To view these articles, visit https://doi.org/10.1111/apt.15701 and https://doi.org/10.1111/apt.15769.

Publication types

Editorial
Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections
Humans
Inflammatory Bowel Diseases*
Pandemics
Pneumonia, Viral
Prevalence
SARS-CoV-2
United Kingdom